U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Guidance for Industry: Recognition of Acceptable Unique Facility Identifier (UFI) for the Foreign Supplier Verification Programs Regulation
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Guidance for Industry: Recognition of Acceptable Unique Facility Identifier (UFI) for the Foreign Supplier Verification Programs Regulation March 2017

Download the Final Guidance Document
Final
Docket Number:
FDA-2011-N-0143
Issued by:
Guidance Issuing Office
Center for Veterinary Medicine
Human Foods Program

This guidance specifies FDA’s current thinking on what unique facility identifier (UFI) FDA recognizes as acceptable for purposes of the Foreign Supplier Verification Programs (FSVP) regulation established in Title 21 of the Code of Federal Regulation, Part 1, subpart L as part of our implementation of the FDA Food Safety Modernization Act (FSMA; Pub. L. 111-353).

The pronoun “you” is used in this guidance to refer to the importer.

FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities.

Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.

The use of the word should in Agency guidances means that something is suggested or recommended, but not required. 

Download the Guidance

Related Information

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2011-N-0143.

Back to Top